Deborah Phippard, PhD, is chief scientific officer at Precision for Medicine. A pharma industry veteran with deep expertise in biomarker-driven clinical trial design and execution, she has led biomarker and drug development programs for pharmaceutical and diagnostics companies and the National Institutes of Health and has spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy.
Deborah Phippard
Opinion author
